Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Coegin Pharma AB: BioStock: Coegin Pharma fuses with Swedish biotech Follicum

Coegin Pharma
Read the release

Soon after receiving the green light from the Danish Medicines Agency for initiating the phase I/II COAK study in actinic keratosis, Nordic biotech Coegin Pharma reveals new plans for growth and expansion through a merger with Swedish biotech Follicum. BioStock spoke with Coegin's CEO Tore Duvold to learn the details of the merger and the future implications for the company.

Read the interview with Tore Duvold at biostock.se:

https://www.biostock.se/en/2021/09/coegin-pharma-fuses-with-swedish-biotech-follicum/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.